Teva stock flirted with a breakout Wednesday after generic drugs helped the Big Pharma behemoth beat June-quarter expectations and hike its outlook for the year. Please watch the video at ...

Big Pharma is able to charge Americans significantly higher prices and pad their profits.” Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.) last month called again on Teva and ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

a subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers, including hospitals, health ...

TEVA) and Royalty Pharma plc (Nasdaq: RPRX), announced today a collaboration to further accelerate the clinical research program for Teva’s olanzapine LAI (TEV-‘749) by entering into a funding ...

Teva's growth is the latest reminder of the way generic drugs and the companies that make them are changing the global pharma landscape. It's no longer correct to think of generics manufacturers ...

Looks like another scale-down is coming to Teva’s board. The Israeli drugmaker ... for a smaller board with more experience in global pharma. That’s Amir Elstein, who at one time looked ...

Much to the relief of shareholders, seemingly endless turmoil at Teva Pharmaceutical TEVA-0.41%decrease; red down pointing triangle Industries has largely subsided. The generic drugs giant ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. TEVA, +1.27% said Friday it has priced an offering of $500 million of 5.55% senior notes due 2016 and $1 billion of 6.15% senior ...

Teva’s betting big on biosimilars and specialty ... For a company that’s often painted as a problem child in pharma, that’s a pretty decent look. But it’s not all sunshine.

Transaction Terms Under the agreement, Royalty Pharma will provide Teva up to $100 million to fund ongoing development costs for olanzapine LAI (TEV-‘749), and Royalty Pharma and Teva have a ...